Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Benzylamine | HCID 7504 | — |
| Reactant | Ethyl chloroformate | HCID 10928 | — |
| Reactant | Diisopropylethylamine | HCID 81531 | — |
| Reactant | HCID 178492007 | HCID 178492007 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | HCID 178473319 | HCID 178473319 | 25% |
Reaction Steps
To a suspension of 0.01 g 2-(4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine hydrochloride in 0.8 ml tetrahydrofurane were added at 0–4° C. 0.06 ml N-ethyldiisopropylamine and 0.003 ml ethyl chloroformate in 0.26 ml tetrahydrofurane. The mixture was refluxed over night, additional 0.06 ml N-ethyldiisopropylamine and 0.05 ml ethyl chloroformate were added and heating was continued for 4 hours. 0.015 ml benzylamine were added and the mixture was kept at 80° C. for 1 hour. Silicagel was added and the solvent was distilled off. The residue was transferred to a column prefilled with silicagel and was chromatographed with ethylacetate. A second chromatography first with ethylacetate/hexane 1:1 and then with ethylacetate/methanol 9:1 yielded 0.003 g (25%) 2-(4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-1,4,6,7-tetrahydro-imidazo[4,5-c]pyridine-5-carboxylic acid ethyl ester as yellow solid; MS (ISP): m/e=444 (M+H+).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07122545B2 |
|---|
| Source dataset | uspto-grants-2006_10 |
|---|
| ORD ID | ord-ac96fba0e28744a2a193d1d1e2a10d69 |
|---|
| Source note | uspto-grants-2006_10 |
|---|